TRIP13 and hepatocellular carcinoma: The genomic-clinicopathologic nomogram demonstrated a C-index of 0.677 (95% CI 0.650–0.704) for OS and a C-index of 0.767 (95% CI 0.737–0.796) for DSS (Fig. 3), thereby further confirming the prognostic value of TRIP13 in HCC.